A carregar...
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
Neuroblastoma (NB) is the most common extracranial solid tumor in children. Aberrant activation of the non-receptor tyrosine kinases Src and c-Abl contributes to the progression of NB. Thus, targeting these kinases could be a promising strategy for NB therapy. In this paper, we report that the poten...
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352070/ https://ncbi.nlm.nih.gov/pubmed/27903968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13643 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|